• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtech stories we missed this week: Dec. 29, 2017

December 29, 2017 By Danielle Kirsh

medtech missed
[Image from unsplash.com]
From NanoVibronix’s new Indian regulatory and distribution agreement to Guided Therapeutics’s Turkish distribution deal, here are five medtech stories we missed this week but thought were still worth mentioning.

1. NanoVibronix inks deal with Indian regulatory and distribution consultant

NanoVibronix announced in a Dec. 20 press release that it has signed Morulaa HealthTech as its regulatory and marketing partner in India. Morulaa HealthTech will help bring NanoVibronix’s products to India, including its UroShield, WoundShield and PainShield. Morulaa HealthTech also has an in-house regulatory team and an established third-party distribution network across India in both rural and urban areas.

2. K2M wins CE Mark for Capri cervical cage

K2M has received CE Mark for its Capri Cervical 3D Expandable Corpectomy Cage System with Lamellar 3D Titanium Technology, according to a Dec. 20 press release. The Capri Cervical 3D Expandable is the first and only 3D-printed expandable device on the market that helps with in-situ height expansion and endplate angulation in the cervical spine. K2M’s cage system also stabilizes the cervical spine in vertebral body resections that happen from trauma or tumor.

3. China clears Impulse Dynamic’s Optimizer cardiac failure device

Impulse Dynamics announced in a Dec. 18 press release that the China Food and Drug Administration has approved its Optimizer system for treatment of chronic heart failure. The device delivers non-excitatory Cardiac Contractility Modulation signals to the heart to help create multiple biochemical and neurohormonal changes to the myocardium. The myocardium contractility increase and causes no concomitant increase in oxygen consumption which allows for the heart to work more efficiently.

Get the full story on our sister site, MassDevice.

Filed Under: Business/Financial News, Cardiovascular, Featured, Orthopedics, Regulatory/Compliance Tagged With: Guided Therapeutics, Impulse Dynamics, K2M, medtech, Muscle Activation Technique, NanoVibronix, NeuX

IN CASE YOU MISSED IT

  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Embecta stock soars on first full-quarter results after BD spinoff
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review
  • Study backs Fluidx embolic device for vessel filling

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS